| pubmed-article:2656494 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2656494 | lifeskim:mentions | umls-concept:C1709854 | lld:lifeskim |
| pubmed-article:2656494 | lifeskim:mentions | umls-concept:C0005953 | lld:lifeskim |
| pubmed-article:2656494 | lifeskim:mentions | umls-concept:C0450127 | lld:lifeskim |
| pubmed-article:2656494 | lifeskim:mentions | umls-concept:C0268731 | lld:lifeskim |
| pubmed-article:2656494 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:2656494 | pubmed:dateCreated | 1989-6-26 | lld:pubmed |
| pubmed-article:2656494 | pubmed:abstractText | A boy with null-cell leukemia received a bone marrow allograft after preparation with chemotherapy and total body irradiation. Cyclosporine A was not administered following transplantation. Renal biopsy performed 6 months after transplantation because of unexplained deterioration of renal function revealed diffuse mesangiolysis and glomerular sclerosis. The significance of this finding is discussed with reference to similar, recently reported cases. | lld:pubmed |
| pubmed-article:2656494 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2656494 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2656494 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2656494 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2656494 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:2656494 | pubmed:issn | 0046-8177 | lld:pubmed |
| pubmed-article:2656494 | pubmed:author | pubmed-author:BrowningM CMC | lld:pubmed |
| pubmed-article:2656494 | pubmed:author | pubmed-author:LorentzW BWB | lld:pubmed |
| pubmed-article:2656494 | pubmed:author | pubmed-author:IskandarS SSS | lld:pubmed |
| pubmed-article:2656494 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2656494 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:2656494 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2656494 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2656494 | pubmed:pagination | 290-2 | lld:pubmed |
| pubmed-article:2656494 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:2656494 | pubmed:meshHeading | pubmed-meshheading:2656494-... | lld:pubmed |
| pubmed-article:2656494 | pubmed:meshHeading | pubmed-meshheading:2656494-... | lld:pubmed |
| pubmed-article:2656494 | pubmed:meshHeading | pubmed-meshheading:2656494-... | lld:pubmed |
| pubmed-article:2656494 | pubmed:meshHeading | pubmed-meshheading:2656494-... | lld:pubmed |
| pubmed-article:2656494 | pubmed:meshHeading | pubmed-meshheading:2656494-... | lld:pubmed |
| pubmed-article:2656494 | pubmed:meshHeading | pubmed-meshheading:2656494-... | lld:pubmed |
| pubmed-article:2656494 | pubmed:meshHeading | pubmed-meshheading:2656494-... | lld:pubmed |
| pubmed-article:2656494 | pubmed:meshHeading | pubmed-meshheading:2656494-... | lld:pubmed |
| pubmed-article:2656494 | pubmed:meshHeading | pubmed-meshheading:2656494-... | lld:pubmed |
| pubmed-article:2656494 | pubmed:meshHeading | pubmed-meshheading:2656494-... | lld:pubmed |
| pubmed-article:2656494 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2656494 | pubmed:articleTitle | Mesangiolytic glomerulopathy in a bone marrow allograft recipient. | lld:pubmed |
| pubmed-article:2656494 | pubmed:affiliation | Department of Pathology, Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC 27103. | lld:pubmed |
| pubmed-article:2656494 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2656494 | pubmed:publicationType | Case Reports | lld:pubmed |
